The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First report of a phase I/II study of DFP-10917, a nucleoside analog, given by continuous infusion (CI) in patients (pts) with relapsed or refractory acute leukemia.
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Delta-Fly Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Elias Jabbour
No Relationships to Disclose
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Tapan M. Kadia
Consulting or Advisory Role - Ariad; Jazz Pharmaceuticals; Kalobios; Novartis
Research Funding - Celgene
 
Courtney Denton Dinardo
Consulting or Advisory Role - Agios
Research Funding - Abbvie; Daiichi Sankyo
 
Naval Guastad Daver
Consulting or Advisory Role - Incyte; Sunesis Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Incyte; Novartis; Sunesis Pharmaceuticals
 
Gautam Borthakur
No Relationships to Disclose
 
Nitin Jain
Honoraria - Novartis; Pharmacyclics
Consulting or Advisory Role - Novartis; Pharmacyclics
Research Funding - Bristol-Myers Squibb; Pfizer; Pharmacyclics; Seagen
 
Jane Waukau
No Relationships to Disclose
 
Monica Kwari
No Relationships to Disclose
 
Barry Douglas Anderson
Employment - Theradex
 
Kenzo Iizuka
Employment - Delta-Fly Pharma
Leadership - Delta-Fly Pharma
Stock and Other Ownership Interests - Delta-Fly Pharma
 
Cheng Jin
Employment - Delta-Fly Pharma
Leadership - Delta-Fly Pharma
Stock and Other Ownership Interests - Delta-Fly Pharma
 
William Plunkett
No Relationships to Disclose